These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33069844)

  • 41. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Lewis J; Dickson DW
    Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
    Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D
    Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology.
    Llorens F; Thüne K; Andrés-Benito P; Tahir W; Ansoleaga B; Hernández-Ortega K; Martí E; Zerr I; Ferrer I
    J Mol Neurosci; 2017 Oct; 63(2):206-215. PubMed ID: 28871468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders.
    Yamazaki Y; Matsubara T; Takahashi T; Kurashige T; Dohi E; Hiji M; Nagano Y; Yamawaki T; Matsumoto M
    PLoS One; 2011; 6(11):e26996. PubMed ID: 22073234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
    Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurofibrillary tau pathology modulated by genetic variation of alpha-synuclein.
    Peuralinna T; Oinas M; Polvikoski T; Paetau A; Sulkava R; Niinistö L; Kalimo H; Hernandez D; Hardy J; Singleton A; Tienari PJ; Myllykangas L
    Ann Neurol; 2008 Sep; 64(3):348-52. PubMed ID: 18661559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propagation of tau pathology in a model of early Alzheimer's disease.
    de Calignon A; Polydoro M; Suárez-Calvet M; William C; Adamowicz DH; Kopeikina KJ; Pitstick R; Sahara N; Ashe KH; Carlson GA; Spires-Jones TL; Hyman BT
    Neuron; 2012 Feb; 73(4):685-97. PubMed ID: 22365544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy.
    Walker JM; Richardson TE; Farrell K; Iida MA; Foong C; Shang P; Attems J; Ayalon G; Beach TG; Bigio EH; Budson A; Cairns NJ; Corrada M; Cortes E; Dickson DW; Fischer P; Flanagan ME; Franklin E; Gearing M; Glass J; Hansen LA; Haroutunian V; Hof PR; Honig L; Kawas C; Keene CD; Kofler J; Kovacs GG; Lee EB; Lutz MI; Mao Q; Masliah E; McKee AC; McMillan CT; Mesulam MM; Murray M; Nelson PT; Perrin R; Pham T; Poon W; Purohit DP; Rissman RA; Sakai K; Sano M; Schneider JA; Stein TD; Teich AF; Trojanowski JQ; Troncoso JC; Vonsattel JP; Weintraub S; Wolk DA; Woltjer RL; Yamada M; Yu L; White CL; Crary JF
    J Neuropathol Exp Neurol; 2021 Jan; 80(2):102-111. PubMed ID: 33367843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease.
    Morawski M; Brückner G; Jäger C; Seeger G; Arendt T
    Neuroscience; 2010 Sep; 169(3):1347-63. PubMed ID: 20497908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles.
    Nishikawa T; Takahashi T; Nakamori M; Yamazaki Y; Kurashige T; Nagano Y; Nishida Y; Izumi Y; Matsumoto M
    Neuropathol Appl Neurobiol; 2014 Jun; 40(4):489-501. PubMed ID: 23631697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional quantitative study of formation process of neurofibrillary tangles in the hippocampus of non-demented elderly brains: comparison with late-onset Alzheimer's disease brains.
    Takayama N; Iseki E; Yamamoto T; Kosaka K
    Neuropathology; 2002 Sep; 22(3):147-53. PubMed ID: 12416553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease.
    Mahady LJ; Perez SE; Malek-Ahmadi M; Mufson EJ
    J Comp Neurol; 2023 Dec; 531(18):2080-2108. PubMed ID: 36989381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.
    Chalermpalanupap T; Weinshenker D; Rorabaugh JM
    Neural Plast; 2017; 2017():7829507. PubMed ID: 29038736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal CA1 neurons in Alzheimer's disease and Pick's disease: a lesion distinct from granulovacuolar degeneration.
    Probst A; Herzig MC; Mistl C; Ipsen S; Tolnay M
    Acta Neuropathol; 2001 Dec; 102(6):636-44. PubMed ID: 11761725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.
    Aragão Gomes L; Uytterhoeven V; Lopez-Sanmartin D; Tomé SO; Tousseyn T; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Verstreken P; Thal DR
    Acta Neuropathol; 2021 Feb; 141(2):173-192. PubMed ID: 33427938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
    Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
    J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.